HIMS Stock Up 120%! More Growth Ahead? Hosted by Bridget BennettFebruary 18, 2025 ShareLink copied to clipboard. Play video for HIMS Stock Up 120%! More Growth Ahead?DetailsGuestsHims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced? MarketBeat analyst Gabriel Osorio-Mazilli breaks down why this telehealth stock is gaining massive momentum, what’s driving its growth, and whether there’s still room to buy.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioHIMSHims & Hers Health3.5918 of 5 stars$28.21+3.6%N/A64.12 Add This Stock to My Watchlist Gabriel Osorio-Mazilli, GuestMarketBeat Contributor, MarketBeatBridget Bennett, HostDigital Media Producer, MarketBeatAlways the talker, Bridget Bennett turned her passion for people and sharing stories into a career in communications. She started working as a journalist in high school at her local county paper in Ellendale, North Dakota. After moving to Dallas for college at Southern Methodist University, she quickly fell in love with visual storytelling and started her career as a news anchor and reporter.Bridget brings her 12 years of experience in broadcast writing and video production to the MarketBeat content team. She's also an energetic, creative thinker and lifelong learner, so she's always bringing new ideas. Bridget is thrilled to be part of an innovative team that is constantly looking to create useful content people can connect with.When she's not working, Bridget is a busy mom of three and can be found at just about every activity or outing in town. She is also an adoption and foster care advocate and helps support foster children and families through her nonprofit volunteer work. She and her husband, Jason, grew up together and have spent their lives exploring the world through travel, hiking and ministry.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored15 Stocks Institutional Investors Are Selling NowHedge funds, endowments, and other institutional investors have been selling shares of these 15 stocks in the ...MarketBeatElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored7 Consumer Discretionary Stocks That Will Continue to RallyConsumer discretionary stocks appear to be among the winners from the ongoing Trump trade following the U.S. p...MarketBeatTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored7 Tech Stocks That Still Offer Good Value for 2025Technology stocks continue to outperform most of the other market sectors. And, even though many investors may...MarketBeat Remove Ads Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersAre Tariffs Threatening Disney’s Comeback Story?April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Now I look stupid. Real stupid... From Porter & Company(Ad)View Now I look stupid. Real stupid... 5 Highest-Rated Dividend Stocks According to MarketBeatApril 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeatBuffett’s Next Oil Bet: Why Occidental Is DifferentApril 8, 2025View Buffett’s Next Oil Bet: Why Occidental Is DifferentIAMGOLD Stock Climbs as Turnaround Story Gains TractionApril 11, 2025View IAMGOLD Stock Climbs as Turnaround Story Gains TractionNow I look stupid. Real stupid... From Porter & Company(Ad)View Now I look stupid. Real stupid... Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Bridget BennettFebruary 18, 2025 ShareLink copied to clipboard. Play video for HIMS Stock Up 120%! More Growth Ahead?DetailsGuestsHims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced? MarketBeat analyst Gabriel Osorio-Mazilli breaks down why this telehealth stock is gaining massive momentum, what’s driving its growth, and whether there’s still room to buy.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioHIMSHims & Hers Health3.5918 of 5 stars$28.21+3.6%N/A64.12 Add This Stock to My Watchlist Gabriel Osorio-Mazilli, GuestMarketBeat Contributor, MarketBeatBridget Bennett, HostDigital Media Producer, MarketBeatAlways the talker, Bridget Bennett turned her passion for people and sharing stories into a career in communications. She started working as a journalist in high school at her local county paper in Ellendale, North Dakota. After moving to Dallas for college at Southern Methodist University, she quickly fell in love with visual storytelling and started her career as a news anchor and reporter.Bridget brings her 12 years of experience in broadcast writing and video production to the MarketBeat content team. She's also an energetic, creative thinker and lifelong learner, so she's always bringing new ideas. Bridget is thrilled to be part of an innovative team that is constantly looking to create useful content people can connect with.When she's not working, Bridget is a busy mom of three and can be found at just about every activity or outing in town. She is also an adoption and foster care advocate and helps support foster children and families through her nonprofit volunteer work. She and her husband, Jason, grew up together and have spent their lives exploring the world through travel, hiking and ministry.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored15 Stocks Institutional Investors Are Selling NowHedge funds, endowments, and other institutional investors have been selling shares of these 15 stocks in the ...MarketBeatElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored7 Consumer Discretionary Stocks That Will Continue to RallyConsumer discretionary stocks appear to be among the winners from the ongoing Trump trade following the U.S. p...MarketBeatTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored7 Tech Stocks That Still Offer Good Value for 2025Technology stocks continue to outperform most of the other market sectors. And, even though many investors may...MarketBeat
